Related Experiment Video
Updated: Jun 8, 2026
06:51
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Clostridium difficile infection and liver disease
Saif Musa1, Carl Moran, Tony Rahman
1Department of Gastroenterology & Hepatology, St. George's Hospital, Blackshaw Rd, London, UK.
Journal of Gastrointestinal and Liver Diseases : JGLD
|October 6, 2010
Summary
Clostridium difficile infection (CDI) is rising globally, particularly impacting patients with liver disease. This review examines CDI in liver disease patients, highlighting worse outcomes and increased costs.
Area of Science:
- Gastroenterology and Hepatology
- Infectious Diseases
- Public Health
Background:
- Clostridium difficile infection (CDI) rates are increasing worldwide, posing a significant public health challenge.
- Patients with pre-existing liver disease are a vulnerable population susceptible to CDI.
- Emerging evidence indicates CDI is linked to poorer outcomes and higher healthcare expenditures in liver disease patients.
Purpose of the Study:
- To review the epidemiology of CDI in patients with liver disease.
- To identify risk factors, pathogenesis, and treatment strategies for CDI in this cohort.
- To analyze the outcomes of CDI in individuals with liver disease.
Main Methods:
- Literature review and synthesis of existing research on CDI and liver disease.
- Analysis of epidemiological data, risk factors, and pathogenesis mechanisms.
- Evaluation of current treatment options and patient outcomes.
Main Results:
- CDI is associated with increased morbidity, mortality, and healthcare costs in patients with liver disease.
- Specific risk factors and altered immune responses contribute to CDI susceptibility in this population.
- Treatment of CDI in liver disease patients requires careful consideration of potential complications and drug interactions.
Conclusions:
- Patients with liver disease represent a critical group for CDI prevention and management strategies.
- Further research is needed to optimize treatment protocols and improve outcomes for CDI in liver disease.
- Effective management of CDI in liver disease patients is essential for reducing healthcare burden.
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...